Selective inhibition of separated forms of cyclic nucleotide phosphodiesterase from rat heart by some cardio- or vaso-active butenolide derivatives.
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000037:antagonists & inhibitors*; D015106:3',5'-Cyclic-GMP Phosphodiesterases / Q000037:antagonists & inhibitors*; D012368:4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone / Q000494:pharmacology; D015107:4-Butyrolactone / Q000031:analogs & derivatives; D000818:Animals; D001572:Benzofurans / Q000494:pharmacology; D001573:Benzoin / Q000031:analogs & derivatives / Q000494:pharmacology; D003600:Cytosol / Q000201:enzymology; D005663:Furans / Q000494:pharmacology*; D007527:Isoenzymes / Q000037:antagonists & inhibitors*; D009206:Myocardium / Q000201:enzymology*; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology; D011688:Purinones / Q000494:pharmacology; D051381:Rats; D014665:Vasodilator Agents / Q000494:pharmacology
D001572:Benzofurans; D005663:Furans; D007527:Isoenzymes; D010726:Phosphodiesterase Inhibitors; D011688:Purinones; D014665:Vasodilator Agents; D012368:4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; C022919:lactonic deoxybenzoin glucoside; C035961:IP 24; C000124:benfurodil; C004511:butenolide; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D015106:3',5'-Cyclic-GMP Phosphodiesterases; C011145:zaprinast; D001573:Benzoin; D015107:4-Butyrolactone